解毒祛瘀滋阴方拮抗糖皮质激素致SLE“肠-脑-LTP轴”损伤的作用与机制研究
批准号:
81973778
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
丁兴红
依托单位:
学科分类:
中医内科学
结题年份:
2023
批准年份:
2019
项目状态:
已结题
项目参与者:
丁兴红
中文摘要
系统性红斑狼疮(SLE)是以免疫性炎症为突出表现的难治性自身免疫病。目前糖皮质激素仍是治疗SLE的基础药物,但存在明显毒副作用。前期研究发现,解毒祛瘀滋阴方(JP)治疗SLE疗效确切,并能修复糖皮质激素致SLE肠道菌群紊乱及下丘脑-垂体-肾上腺轴(HPA轴)抑制,但作用机制不明。最新研究表明:神经元长时程增强(LPT)损伤与HPA抑制正相关,而NMDA受体是表征LTP损伤的关键因子。预实验发现:JP可以保护SLE小鼠神经系统,并修复糖皮质激素致SLE小鼠LTP损伤。基于此,本课题将从整体与细胞层面研究JP对糖皮质激素致LTP损伤的拮抗作用,通过JP修复SLE小鼠肠道菌群和免疫球蛋白A,改善HPA轴功能,调控Glu/GABA动态平衡及NMDA受体功能变化,阐明JP拮抗糖皮质激素致SLE“肠-脑-LTP轴”损伤作用与机制,为中医治疗SLE提供新思路。
英文摘要
Systemic lupus erythematosus (SLE) is a refractory autoimmune disease characterized by immune inflammation. Currently, glucocorticoid (GC) is still the basic drug for SLE, but there are obvious toxic and effects. Preliminary studies indicated that JieduQuyuZiyin prescription (JP) has a definite therapeutic effect on SLE,and can repair intestinal flora disturbance and hypothalamic-pituitary-adrenal axis (HPA axis) function in SLE induced by GC,but its mechanism is not clear.Recent studies have shown that long-term potentiation (LTP) of hippocampal neurons is positively correlated with HPA inhibition, and NMDA receptor function may be the key factor to characterize the LTP damage. Our preliminary experiments reveal that JP can antagonize the LTP damage induced by GC in SLE mice and repair its nervous system. In this study, synaptic plasticity damage model of SLE mice induced by GC was established from the holistic and cellular level, and then will be administered by JP. We would explore the changes of intestinal flora and secretory immunoglobulin A (SIgA) and HPA axis function inhibition in SLE mice, and to further explore the functional changes of NMDA receptor by combining the dynamic balance of Glu and GABA.Finally, we would clarify the role and mechanism of JP in repairing intestine-brain-LTP damage in SLE mice induced by GC, and provide new ideas for clinical treatment of SLE in Traditional Chinese Medicine.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
登录
查看更多内容
DOI:
10.3389/fphar.2022.988512
发表时间:
2022
期刊:
Frontiers in pharmacology
影响因子:
5.6
作者:
[]
通讯作者:
DOI:
--
发表时间:
2023
期刊:
中国中西医结合杂志
影响因子:
作者:
[李杰, 范永升, 丁兴红]
通讯作者:
丁兴红
DOI:
10.1016/j.brainres.2023.148270
发表时间:
2023-02-19
期刊:
BRAIN RESEARCH
影响因子:
2.9
作者:
[Wang,Yao, Xiang,Shate, Ding,Xinghong]
通讯作者:
Ding,Xinghong
Pristane cadmium chloride nanoemulsion accelerates the onset of systemic lupus erythematosus in a C57BL/6 mouse model
降植烷氯化镉纳米乳加速 C57BL/6 小鼠模型中系统性红斑狼疮的发病
DOI:
--
发表时间:
2023
期刊:
Lupus
影响因子:
2.6
作者:
[Yi, Suhai Qian, Shate Xiang, Jingjing Zhang, Meng Zhang, Xing]
通讯作者:
Xing
DOI:
--
发表时间:
2022
期刊:
中华中医药杂志
影响因子:
作者:
[钱苏海, 金艺波, 丁兴红, 钱俊华, 范永升]
通讯作者:
范永升
共 7 条
解毒祛瘀滋阴法通过SCAP-SREBP2信号轴调控生发中心B细胞异常活化改善SLE的作用机制研究
-
批准号:82574898
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:丁兴红
-
依托单位:
从解毒祛瘀滋阴法下调PM2.5诱发的NET-pDC-IFN-α通路探讨其治疗SLE的作用与机制
-
批准号:81774179
-
项目类别:面上项目
-
资助金额:53.0万元
-
批准年份:2017
-
负责人:丁兴红
-
依托单位:
基于HPLC-NMR技术的解毒祛瘀滋阴方治疗系统性红斑狼疮的代谢组学研究
-
批准号:81001515
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:丁兴红
-
依托单位:
国内基金
海外基金